Rigel Pharmaceuticals, Inc. (RIGL)

36.79 -0.69 (-1.84%) USD  |  NASDAQ  |  Jan 20, 09:49
More

Rigel Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade